KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) EBT Margin (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of EBT Margin data on record, last reported at 4.37% in Q4 2025.

  • For Q4 2025, EBT Margin rose 2887.0% year-over-year to 4.37%; the TTM value through Dec 2025 reached 10.09%, up 681.0%, while the annual FY2025 figure was 10.09%, 681.0% up from the prior year.
  • EBT Margin reached 4.37% in Q4 2025 per ZBH's latest filing, down from 13.95% in the prior quarter.
  • Across five years, EBT Margin topped out at 15.66% in Q1 2023 and bottomed at 38.03% in Q4 2021.
  • Average EBT Margin over 5 years is 4.78%, with a median of 11.26% recorded in 2021.
  • Peak YoY movement for EBT Margin: crashed -7411bps in 2021, then soared 4721bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 38.03% in 2021, then soared by 124bps to 9.18% in 2022, then plummeted by -507bps to 37.41% in 2023, then surged by 34bps to 24.51% in 2024, then soared by 118bps to 4.37% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 4.37% in Q4 2025, 13.95% in Q3 2025, and 10.81% in Q2 2025.